| Literature DB >> 24009886 |
Olivier G de Jong1, Marianne C Verhaar, Yong Chen, Pieter Vader, Hendrik Gremmels, George Posthuma, Raymond M Schiffelers, Marjan Gucek, Bas W M van Balkom.
Abstract
BACKGROUND: The healthy vascular endothelium, which forms the barrier between blood and the surrounding tissues, is known to efficiently respond to stress signals like hypoxia and inflammation by adaptation of cellular physiology and the secretion of (soluble) growth factors and cytokines. Exosomes are potent mediators of intercellular communication. Their content consists of RNA and proteins from the cell of origin, and thus depends on the condition of these cells at the time of exosome biogenesis. It has been suggested that exosomes protect their target cells from cellular stress through the transfer of RNA and proteins. We hypothesized that endothelium-derived exosomes are involved in the endothelial response to cellular stress, and that exosome RNA and protein content reflect the effects of cellular stress induced by hypoxia, inflammation or hyperglycemia.Entities:
Keywords: RNA; exosomes; extracellular vesicles; hypoxia; proteomics; tumor necrosis factor alpha
Year: 2012 PMID: 24009886 PMCID: PMC3760650 DOI: 10.3402/jev.v1i0.18396
Source DB: PubMed Journal: J Extracell Vesicles ISSN: 2001-3078
Fig. 1Characterization of endothelial cell-derived exosomes. Vesicles in the final, washed 100,000g pellets from endothelial cell culture supernatant cultured under standard conditions were analysed by sucrose density gradient and subsequent immunoblotting for Flotillin-1 (a), transmission electron microscopy (b; 10 nm gold: CD63) and by NTA (c). Size distributions of vesicles in washed 100,000g pellets from supernatants of stress-exposed endothelial cells were compared by NTA (d–g; conditions indicated, grey area represents SD).
Proteins showing differential abundances: top up- and downregulated proteins, compared to control (>1.25-fold)
| Condition | Protein | Full name | NP number | Fold (±SD) |
|---|---|---|---|---|
| Hypoxia | SEMG1 | Semenogelin 1 | NP_002998.1 | 6.39 (2.44) |
| CO4A | Complement component 4A | NP_009224.2 | 2.56 (0.77) | |
| LOXL2 | Lysyl oxidase-like 2 | NP_002309.1 | 2.30 (0.53) | |
| CO1A1 | Collagen, type 1, alpha 1 | NP_000079.2 | 0.74 (0.27) | |
| AN32E | Acidic (leucine-rich) nuclear phosphoprotein 32 family, member E | NP_112182.1 | 0.79 (0.24) | |
| EPN1 | Epsin 1 | NP_037465.2 | 0.84 (0.23) | |
| TNF-α | TNIP1 | TNFAIP3 interacting protein 1 | NP_006049.3 | 6.60 (4.70) |
| TNFAIP3 | Tumor necrosis factor, alpha-induced protein 3 | NP_006281.1 | 6.60 (2.50) | |
| ICAM1 | Intracellular adhesion molecule 1 | NP_000192.2 | 1.93 (0.41) | |
| CO5 | Complement component 5 | NP_001726.2 | 0.79 (0.09) | |
| APOM | Apolipoprotein M | NP_061974.2 | 0.84 (0.22) | |
| COIA1 | Collagen, type XVIII, alpha 1 | NP_569712.2 | 0.88 (0.18) | |
| Glucose | ASPC1 | Alveolar soft part sarcoma chromosome region, candidate 1 | NP_076988.1 | 1.49 (0.80) |
| TENX | Tenascin-XB | NP_115859.2 | 1.27 (0.39) | |
| CO4A | Complement component 4A | NP_009224.2 | 0.47 (0.17) | |
| CO5 | Complement component 5 | NP_001726.2 | 0.77 (0.13) | |
| Mannose | SMD3 | Small nuclear ribonucleoprotein D3 polypeptide 18 kDa | NP_004166.1 | 1.64 (0.26) |
| SFXN1 | Sideroflexin 1 | NP_073591.2 | 1.36 (0.25) | |
| CO4A | Complement component 4A | NP_009224.2 | 0.48 (0.14) |
Fig. 2Verification of quantitative proteomics data by immunoblotting. Differences observed in quantitative proteomics, expressed as mean±SD based on analysis of individual quantified peptides (a–c) were verified by immunoblotting (d–f).
RNAs showing significant differential abundances (hypoxia, TNF-α): differentially abundant mRNAs
| Condition | Gene | NM number | Fold change | Adj. p value |
|---|---|---|---|---|
| Hypoxia | NDRG1 | NM_006096.2 | 1.376 | 0.003 |
| CIRBP | NM_001280.1 | 0.810 | 0.029 | |
| BNIP3 | NM_004052.2 | 1.231 | 0.044 | |
| TNF | CCL2 | NM_002982.3 | 3.242 | 0.000 |
| IL8 | NM_000584.2 | 4.103 | 0.000 | |
| TNIP1 | NM_006058.3 | 1.500 | 0.000 | |
| IL1B | NM_000576.2 | 1.396 | 0.000 | |
| SOD2 | NM_001024465.1 | 1.701 | 0.000 | |
| VCAM1 | NM_001078.2 | 1.251 | 0.000 | |
| IL32 | NM_001012633.1 | 1.706 | 0.000 | |
| BIRC3 | NM_001165.3 | 1.221 | 0.000 | |
| NFKB1 | NM_003998.2 | 1.358 | 0.003 | |
| EFNA1 | NM_004428.2 | 1.205 | 0.004 | |
| CCL5 | NM_002985.2 | 1.218 | 0.011 | |
| RPS7 | NM_001011.3 | 1.285 | 0.011 | |
| BIRC2 | NM_001166.3 | 1.338 | 0.017 | |
| APBA3 | NM_004886.3 | 1.121 | 0.025 | |
| MT1A | NM_005946.2 | 1.815 | 0.027 | |
| CDV3 | NM_017548.3 | 1.241 | 0.032 | |
| NFKBIA | NM_020529.1 | 1.648 | 0.045 | |
| LOC375295 | XM_374020.4 | 0.835 | 0.046 |
Fig. 3Analysis and verification of exosome mRNA profiles. Quantitative PCR confirms differential abundance of mRNAs identified to be significantly increased or decreased in exosomes from hypoxia (a) or TNF-α exposed cells compared to those from control cells (b), error bars represent SEM, *p < 0.05. Clustering analysis based on the 100 most variable mRNAs distinguishes exosomes from endothelial cells exposed to hypoxia or TNF-α, but not to high glucose or mannose, from control cell-derived exosomes (c).